Biocon Limited
Biocon Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: BIOCON and BSE: 532523 (ISIN INE376G01013).
It has a market capitalisation of ₹55,114 crore, a last close of ₹340.00 on 2026-10-19, a one-year return of -4.5%.
Valuation: a price-to-earnings ratio of 111x, a price-to-book ratio of 1.62x, a dividend yield of 0.1%.
Profitability: return on equity of 1.4%, return on capital employed of 3.1%, an operating margin of 20.4%.
Growth: sales growth of 14.8% a year over three years, net profit growth of -5.9% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.44x, promoter holding of 44.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 55,114 |
| Last close | ₹340.00 |
| P/E (TTM) | 111x |
| P/B | 1.62x |
| Dividend yield | 0.1% |
| ROE (FY) | 1.4% |
| ROCE (FY) | 3.1% |
| Operating margin (TTM) | 20.4% |
| Sales growth, 3-year CAGR | 14.8% |
| Profit growth, 3-year CAGR | -5.9% |
| Debt / equity | 0.44x |
| Promoter holding | 44.7% |
| 1-year return | -4.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means